https://pharmoniq.com/news/fda-approves-pirtobrutinib-first-line-blood-cancer-treatment PharmoniQ en 2026-10-06T14:10:49.397Z FDA Approves Pirtobrutinib as First-Line Blood Cancer Treatment FDA approval, oncology, blood cancer, pirtobrutinib, Eli Lilly https://pharmoniq.com/news/shionogi-acquires-intrabio-2-billion-rare-disease-expansion PharmoniQ en 2026-10-06T08:47:02.190Z Shionogi Acquires IntraBio for $2B in Rare Disease Push mergers-acquisitions, rare-disease, shionogi, biotech, orphan-drugs https://pharmoniq.com/news/pharmacists-lipoprotein-a-testing-cardiovascular-risk-management PharmoniQ en 2026-10-05T14:10:49.195Z Pharmacists Take Lead Role in Lp(a) Testing, Cardiovascular Prevention cardiovascular, lipoprotein(a), pharmacist-clinical-role, statin-adherence, preventive-cardiology